These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 11967720

  • 1. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors.
    Rehman A, Rahman AR, Rasool AH.
    J Hum Hypertens; 2002 Apr; 16(4):261-6. PubMed ID: 11967720
    [Abstract] [Full Text] [Related]

  • 2. The effects of angiotensin II on pulse wave velocity in healthy humans.
    Rehman A, Rahman AR, Rasool AH, Naing NN.
    Int J Clin Pharmacol Ther; 2001 Oct; 39(10):423-30. PubMed ID: 11680667
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteers.
    Gossmann J, Burkhardt R, Harder S, Lenz T, Sedlmeyer A, Klinkhardt U, Haak T, Geiger H, Scheuermann EH.
    Clin Pharmacol Ther; 2000 Nov; 68(5):501-9. PubMed ID: 11103753
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism.
    Mitchell A, Rushentsova U, Siffert W, Philipp T, Wenzel RR.
    Clin Pharmacol Ther; 2006 Mar; 79(3):274-81. PubMed ID: 16513451
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II type 1 receptor blockade with 80 and 160 mg valsartan in healthy, normotensive subjects.
    Latif F, Tandon S, Obeleniene R, Hankins SR, Berlowitz MS, Ennezat PV, Le Jemtel TH.
    J Card Fail; 2001 Sep; 7(3):265-8. PubMed ID: 11561228
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 3rd communication: hemodynamic effects of valsartan in rats and dogs.
    Hayashi N, Yamamoto S, Kometani M, Nakao K.
    Arzneimittelforschung; 1997 May; 47(5):620-5. PubMed ID: 9205775
    [Abstract] [Full Text] [Related]

  • 11. [Effects of angiotensin II on inflammation mediators in healthy subjects].
    Lottermoser K, Ulrich-Merzenich G, Vetter H, Düsing R.
    Dtsch Med Wochenschr; 2003 Nov 21; 128(47):2470-5. PubMed ID: 14628252
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 21; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diastolic blood pressure is an important determinant of augmentation index and pulse wave velocity in young, healthy males.
    Nürnberger J, Dammer S, Opazo Saez A, Philipp T, Schäfers RF.
    J Hum Hypertens; 2003 Mar 21; 17(3):153-8. PubMed ID: 12624604
    [Abstract] [Full Text] [Related]

  • 18. [Associations and related factors between pulse wave velocity and arterial system and augmentation index measured on different sites in a healthy population].
    Zhang MH, Ye P, Luo LM, Xiao WK, Wu HM, Liu DJ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Nov 21; 38(11):998-1005. PubMed ID: 21215229
    [Abstract] [Full Text] [Related]

  • 19. Reduction in arterial stiffness with angiotensin II antagonism and converting enzyme inhibition. A comparative study among malay hypertensive subjects with a known genetic profile.
    Rehman A, Ismail SB, Naing L, Roshan TM, Rahman AR.
    Am J Hypertens; 2007 Feb 21; 20(2):184-9. PubMed ID: 17261465
    [Abstract] [Full Text] [Related]

  • 20. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.
    Protogerou A, Blacher J, Stergiou GS, Achimastos A, Safar ME.
    J Am Coll Cardiol; 2009 Feb 03; 53(5):445-51. PubMed ID: 19179203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.